1. A Comparison of High-Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML. Issue 6 (December 2018) Authors: Schwarer, Anthony P.; Butler, Jason; Jackson, Kathryn; Beligaswatte, Ashanka; Martin, Louisa; Kennedy, Glen; Daniela, Zantomio; Lewis, Ian; Hiwase, Devendra; Wight, Joel; He, Simon; Grigg, Andrew; Morris, Kirk; Mollee, Peter; Marlton, Paula Journal: HemaSphere Issue: Volume 2:Issue 6(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A multi‐centre, single‐arm, open‐label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R‐ITP1000 study). (11th July 2014) Authors: Tran, Huyen; Brighton, Tim; Grigg, Andrew; McRae, Simon; Dixon, Joanna; Thurley, Daniel; Gandhi, Maher K.; Truman, Matt; Marlton, Paula; Catalano, John Journal: British journal of haematology Issue: Volume 167:Number 2(2014:Oct.) Page Start: 243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia. Issue 5 (May 2015) Authors: He, Simon Z.; Busfield, Samantha; Ritchie, David S.; Hertzberg, Mark S.; Durrant, Simon; Lewis, Ian D.; Marlton, Paula; McLachlan, Andrew J.; Kerridge, Ian; Bradstock, Kenneth F.; Kennedy, Glen; Boyd, Andrew W.; Yeadon, Trina M.; Lopez, Angel F.; Ramshaw, Hayley S.; Iland, Harry; Bamford, Simone;... Journal: Leukemia & lymphoma Issue: Volume 56:Issue 5(2015:May) Page Start: 1406 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A phase II study of a modified hyper-CVAD frontline therapy for patients with adverse risk diffuse large B-cell and peripheral T-cell non-Hodgkin lymphoma. Issue 4 (21st March 2019) Authors: Hapgood, Greg; Stone, Janey M.; Zannino, Diana; George, Anup; Marlton, Paula; Prince, Henry Miles; Hui, Chi-Hung; Prosser, Ian; Lewis, Ian D.; Bradstock, Kenneth; Seymour, John F. Journal: Leukemia & lymphoma Issue: Volume 60:Issue 4(2019) Page Start: 904 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A phase III randomized trial of high‐dose CEOP + filgrastim versus standard‐dose CEOP in patients with non‐Hodgkin lymphoma: 10‐year follow‐up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial. Issue 5 (21st February 2014) Authors: Hertzberg, Mark; Matthews, Jane Palfrey; Stone, Janey Malka; Dubosq, Ming‐Celine; Grigg, Andrew; Ellis, David; Benson, Warwick; Browett, Peter; Horvath, Noemi; Januszewicz, Henry; Abdi, Ehtesham; Green, Michael; Bonaventura, Anthony; Marlton, Paula; Cannell, Paul; Wolf, Max Journal: American journal of hematology Issue: Volume 89:Issue 5(2014:May) Page Start: 536 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia. (21st August 2014) Authors: Bradstock, Kenneth F.; Link, Emma; Collins, Marnie; Di Iulio, Juliana; Lewis, Ian D.; Schwarer, Anthony; Enno, Arno; Marlton, Paula; Hahn, Uwe; Szer, Jeff; Cull, Gavin; Seymour, John F.; the Australasian Leukaemia and Lymphoma Group Journal: British journal of haematology Issue: Volume 167:Number 5(2014:Dec.) Page Start: 618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Author reply. Issue 10 (10th October 2019) Authors: Trotman, Judith; Cheah, Chan Y.; Marlton, Paula; Opat, Stephen Journal: Internal medicine journal Issue: Volume 49:Issue 10(2019) Page Start: 1338 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study). (20th September 2016) Authors: Ho, P. Joy; Tay, Lay; Teo, Juliana; Marlton, Paula; Grigg, Andrew; St Pierre, Tim; Brown, Greg; Badcock, Caro‐Anne; Traficante, Robert; Gervasio, Othon L.; Bowden, Donald K. Journal: European journal of haematology Issue: Volume 98:Number 2(2017:Feb.) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemia. (February 2016) Authors: Roboz, Gail J; Montesinos, Pau; Selleslag, Dominik; Wei, Andrew; Jang, Jun-Ho; Falantes, Jose; Voso, Maria T; Sayar, Hamid; Porkka, Kimmo; Marlton, Paula; Almeida, Antonio; Mohan, Sanjay; Ravandi, Farhad; Garcia-Manero, Guillermo; Skikne, Barry; Kantarjian, Hagop Journal: Future oncology Issue: Volume 12:Number 3(2016) Page Start: 293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FLT3‐ITD positive acute myeloid leukemia: A retrospective analysis of the role of allogeneic transplant and allelic ratio in patient management. (31st January 2018) Authors: Taylor, Emma; Morris, Kirk; Ellis, Marc; Marlton, Paula; Baveshi, Ketan; Clarey, Joseph; Irving, Ian; Cochrane, Tara; Kennedy, Glen Journal: Asia-Pacific journal of clinical oncology Issue: Volume 14(2018)Supplement 6 Page Start: 426 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗